GBM-initiating cells induce mTOR expression in microglia of mouse models, and the mTOR-mediated signaling of STAT3 and NF-κB contributes to the M2-like microglial phenotype, which hinders infiltration of effector T-cells, tumor proliferation, and immune responses [163]. The gene discussed is NFKB1; the disease is glioblastoma.